Last reviewed · How we verify
NCT05409001
Falls From Sitting to Standing
trial testing tomography pan scan in Falls, Tomography of the Head, Cervical Spine, Chest, Abdomen, and Pelvis in 751 participants. Completed in 9 May 2022.
9 May 2022
Quick facts
| Lead sponsor | Northwell Health |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 751 |
| Start date | 6 October 2020 |
| Primary completion | 9 May 2022 |
| Estimated completion | 9 May 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- tomography pan scan
Conditions studied
- Falls, Tomography of the Head, Cervical Spine, Chest, Abdomen, and Pelvis — all drugs for Falls, Tomography of the Head, Cervical Spine, Chest, Abdomen, and Pelvis →
Sponsor
Northwell Health — full company profile →
Who can join
65 and older, any sex, with Falls, Tomography of the Head, Cervical Spine, Chest, Abdomen, and Pelvis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: When evaluating trauma patients, many centers perform computed tomography of the head, cervical spine, chest, abdomen, and pelvis, the so-called "pan-scan." Here, we evaluate the utility of pan-scan in geriatric patients who sustained ground-level falls. Study Design: We performed a retrospective review of consecutive patients from the trauma registry of a large, urban Level 1 trauma center. Inclusion criteria were registration during the 2019 calendar year, age ≥ 65, mechanism of fall from either sitting or standing, and performance of "pan-scan" at time of assessment. Patient demographics, physical exam findings, CT results, injuries, and patient disposition were recorded. The sensitivity, specificity, positive and negative predictive values of the physical exam for significant injuries were calculated.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Physical exam is not an accurate predictor of injury in geriatric patients with low-energy blunt trauma - A retrospective cohort study.
Kania T, Pandya S, Demissie S, Abdelhalim D, et al · · 2022 · cited 6× · PMID 36147051 · DOI 10.1016/j.amsu.2022.104503
Verify or expand the search:
- PubMed search for NCT05409001
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Northwell Health trials
Trials by the same sponsor.
- NCT07253662 — Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Aden · Phase 1 · recruiting
- NCT07191041 — Emotional Urinary Tract Infection · not yet recruiting
- NCT07254091 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer · EARLY_PHASE1 · recruiting
- NCT07344961 — Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB) · recruiting
- NCT07193862 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Meta · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05409001 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwell Health
- Last refreshed: 7 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05409001.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing